Nuzenio

Mironid

Mironid news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 10 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Glasgow-based Mironid raises €39.9 million in Series B to advance rare kidney disease treatment - EU-StartupsEU-Startups · Fri, 07 Aug 2026 12:14:34 GMT Mironid lands $46M Series B to take kidney drug into clinic - European Biotechnology MagazineEuropean Biotechnology Magazine · Thu, 06 Aug 2026 12:13:31 GMT Scottish National Investment Bank backs Glasgow firm with £8.4m - The HeraldThe Herald · Thu, 06 Aug 2026 05:06:44 GMT Scottish kidney disease biotech Mironid raises $46 million to advance rare disease pipeline - The Pharma LetterThe Pharma Letter · Wed, 05 Aug 2026 16:12:39 GMT Mironid raises USD 46m to advance first-in-class ADPKD therapy - AllSciAllSci · Wed, 05 Aug 2026 15:58:20 GMT Glasgow Biotech Mironid Secures £34m Series B Funding - digit.fyidigit.fyi · Wed, 05 Aug 2026 15:34:16 GMT Mironid Secures $46m To Advance Rare Disease Therapeutics - eurekamagazine.co.ukeurekamagazine.co.uk · Wed, 05 Aug 2026 13:37:33 GMT Mironid banks $46m in Series B to take rare kidney disease drug closer to clinic - Pharmaceutical TechnologyPharmaceutical Technology · Wed, 05 Aug 2026 11:02:58 GMT

Timeline

Fri, 07 Aug 2026 12:14:34 GMTGlasgow-based Mironid raises €39.9 million in Series B to advance rare kidney disease treatment - EU-Startups

Thu, 06 Aug 2026 12:13:31 GMTMironid lands $46M Series B to take kidney drug into clinic - European Biotechnology Magazine

Thu, 06 Aug 2026 05:06:44 GMTScottish National Investment Bank backs Glasgow firm with £8.4m - The Herald

Wed, 05 Aug 2026 16:12:39 GMTScottish kidney disease biotech Mironid raises $46 million to advance rare disease pipeline - The Pharma Letter

Wed, 05 Aug 2026 15:58:20 GMTMironid raises USD 46m to advance first-in-class ADPKD therapy - AllSci

Wed, 05 Aug 2026 15:34:16 GMTGlasgow Biotech Mironid Secures £34m Series B Funding - digit.fyi

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

Series B6 live mentions Glasgow3 live mentions European Biotechnology Magazine3 live mentions The Pharma Letter3 live mentions Scottish2 live mentions USD2 live mentions ADPKD2 live mentions Glasgow Biotech Mironid2 live mentions Secures2 live mentions Series B Funding2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Mironid.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.